JMP Continues To Recommend Intermune At Current Levels By: Benzinga via Benzinga June 13, 2014 at 08:12 AM EDT In a research note released Thursday, JMP analyst Liisa A. Bayko increased the price target on Intermune (NASDAQ: ITMN) from $48 to $55 ... Read More >> Related Stocks: JMP Group Inc